CTSS inhibition could alleviate hyperglycemia-induced endothelial inflammation in vitro, and reduce hepatic glucose production in murine models, while maintaining unaltered glucose metabolism in skeletal myotubes and adipocytes (29, 32). This evidence concerns the gene CTSS and Hyperglycemia.